» Authors » Erick Juarez

Erick Juarez

Explore the profile of Erick Juarez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 719
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shapiro A, Sarkis E, Acloque J, Free A, Gonzalez-Rojas Y, Hussain R, et al.
Open Forum Infect Dis . 2023 Aug; 10(8):ofad354. PMID: 37577112
Background: Convenient administration of coronavirus disease 2019 (COVID-19) treatment in community settings is desirable. Sotrovimab is a pan-sarbecovirus dual-action monoclonal antibody formulated for intravenous (IV) or intramuscular (IM) administration for...
2.
Moya J, Temech M, Parra S, Juarez E, Hernandez-Loy R, Gutierrez J, et al.
Open Forum Infect Dis . 2023 Jul; 10(7):ofad344. PMID: 37520411
Background: Five hundred milligrams of intravenous (IV) sotrovimab has been shown to be well tolerated and efficacious against pre-Omicron strains in treating patients with mild to moderate coronavirus disease 2019...
3.
Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci D, et al.
JAMA . 2022 Mar; 327(13):1236-1246. PMID: 35285853
Importance: Older patients and those with comorbidities who are infected with SARS-CoV-2 may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody for the treatment of...
4.
Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci D, et al.
N Engl J Med . 2021 Oct; 385(21):1941-1950. PMID: 34706189
Background: Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovirus monoclonal antibody that was designed to prevent...